GA can suppress systemic inflammatory response syndrome (SIRS) associated anti-inflammatory response manifestation via inhibition of CC chemokine ligand 2 (CCL2) production by PMN. This evidence concerns the gene CCL2 and systemic inflammatory response syndrome.